Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring.
Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring
Each component has a specific meaning:
Note: Interpret the fabry severity result against the thresholds and context described above.
Enter the cardiac, renal, neurological, cerebrovascular domains for the scenario you are assessing. Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring. Use the fabry severity result to inform your calculation.